Women who have endured traumatic pregnancies such as severe preeclampsia, eclampsia and HELLP syndrome have a higher incidence of PTSD and PPMD than women without these complications.
Resultados de varios estudios apoyan la hipótesis de que el estrés causado por un embarazo y parto traumáticos puede en muchas ocasiones anular la habilidad de salir adelante emocionalmente, llevando a complicaciones psiqui&aacut...
The U.S. Preventive Services Task Force (USPSTF) released today a final recommendation statement on screening for hypertensive disorders of pregnancy. The Task Force recommends that all pregnant people have their blood pressure measured throughout pr...
Abt Associates, together with subcontractors HealthBegins and the MoMMA’s Voices program of the Preeclampsia Foundation, will provide technical assistance and evaluation support to 36 HRSA-supported health centers who are implementing innovative appr...
Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recipients.
Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recipients. These highly competitive monetary awards re...
New preeclampsia research funded by Preeclampsia Foundation Peter J. Pappas grant finds distinct genetic traits of early-onset preeclampsia.
Preeclampsia survivors and their supporters will hit the pavement with a purpose on Saturday, August 26, as part of the fourth annual Promise Walk Wherever event sponsored by the Preeclampsia Foundation.
A recent meta-analysis of 130 preeclampsia prevention trials found some successful strategies but demonstrated the need for more research.
Self-monitoring of blood pressure outside the doctor’s office may help identify women with masked hypertension during pregnancy.
Research study suggests that planned delivery at term (37 weeks) may be an intervention worthy of consideration in women at high-risk for preeclampsia.
This study looked at whether a genome wide analysis study could identify and use maternal DNA variation to predict preeclampsia and gestational hypertension.
Our advocacy objectives are centered on providing patient support and education, raising public awareness, increasing research investment, and improving healthcare practices and quality.
Want to impact how your state and our nation handles maternity care?
Educating patients is the first line of defense when it comes to proper recognition and reporting of symptoms of preeclampsia.
Our purpose is to improve the outcomes of hypertensive disorders of pregnancy by educating, supporting and engaging the community, improving healthcare practices, and finding a cure.